The detection of CA9 in tumour samples, the positive HeLa control and leukoplakias confirmed the efficacy of the method used; therefore, the CA9 expression levels in the blood of patients with leukoplakia were very low and did not differ from those found in healthy tissues and blood controls. This evidence concerns the gene CA9 and leukoplakia.